What is the management of suspected sepsis in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Suspected Sepsis in Pregnancy

Initiate the SEP-1 3-hour bundle immediately upon positive sepsis screen with suspected infection: obtain blood cultures, administer broad-spectrum antibiotics within 1 hour for high-risk patients or within 3 hours for others, measure lactate, and begin aggressive fluid resuscitation with 1-2 L crystalloid. 1

Immediate Recognition and Initial Actions (0-3 Hours)

Diagnostic Approach

  • Use a 3-stage screening process: First-stage alert triggers second-stage evaluation with SIRS or modified obstetric SIRS (omSIRS) criteria depending on gestational age, followed by bedside clinical assessment 1
  • Consider sepsis in any pregnant patient with unexplained end-organ damage and suspected infection, regardless of fever presence 2, 3
  • Critical caveat: Do NOT use lactate elevation alone to diagnose sepsis during active labor, as labor itself, hepatic disease, metformin, and bleeding can elevate lactate 1
  • Normal lactate in pregnancy outside labor is <2 mmol/L 1

Antimicrobial Therapy

  • Administer antibiotics within 1 hour for possible septic shock or high likelihood of sepsis 1
  • For suspected infection without shock signs, antibiotics may be given within 3 hours with close monitoring 1
  • Obtain blood cultures before antibiotic administration when feasible, but never delay antibiotics for cultures 1, 3

Recommended antibiotic regimens (based on 2022 Infectious Diseases Society of America review):

  • Piperacillin-tazobactam as first-line 1
  • Ertapenem as alternative 1
  • Ceftriaxone plus metronidazole for reliable gram-positive, gram-negative, and anaerobic coverage 1
  • Avoid traditional gentamicin-clindamycin-penicillin regimens due to increasing resistance patterns in Enterobacterales and Bacteroides species to early-generation β-lactams, aminoglycosides, and clindamycin 1
  • If aminoglycosides are used, dose at 7 mg/kg (not 5 mg/kg) per updated 2023 CLSI breakpoints 1

Fluid Resuscitation

  • Administer 1-2 L of balanced crystalloid solution within the first 3 hours for hypotension or suspected organ hypoperfusion 1, 3
  • Use balanced crystalloids as first-line (NOT starches or gelatin) 3
  • Continue fluid resuscitation guided by dynamic measures of preload and ongoing assessment 3

Laboratory and Source Control

  • Measure serum lactate level immediately 1, 3
  • Obtain appropriate cultures: blood, urine, respiratory, and others as indicated 2, 3
  • Rapidly identify anatomic source of infection and perform emergency source control when indicated 3
  • If uterine source suspected: Proceed with prompt delivery or evacuation of uterine contents regardless of gestational age 3

Escalation to 6-Hour Bundle (Septic Shock Management)

Indications for 6-Hour Bundle

  • Persistent hypotension after fluid administration 1
  • Initial lactate ≥4 mmol/L 1
  • Failure to stabilize with 3-hour bundle interventions 1

Vasopressor Therapy

  • Norepinephrine is the first-line vasopressor starting at 0.02 µg/kg/min, titrated to maintain MAP ≥65 mmHg 1, 3
  • Consider peripheral initiation until central access established 1
  • If inadequate MAP despite low-moderate norepinephrine dose (0.1-0.2 µg/kg/min), add vasopressin 0.04 units/min 1
  • For cardiac dysfunction with persistent hypoperfusion, consider adding epinephrine 1
  • Initiate low-dose corticosteroids (hydrocortisone 200 mg/day as 50 mg IV every 6 hours) if no response to norepinephrine or epinephrine ≥0.25 µg/kg/min for at least 4 hours 1, 3

Hemodynamic Monitoring

  • Consider invasive arterial blood pressure monitoring 1
  • Use non-invasive hemodynamic monitoring to guide continued fluid resuscitation until patient stabilizes or pulmonary edema develops 1
  • Repeat lactate within 6 hours if initially elevated 1

Pregnancy-Specific Considerations

Antibiotic Dosing in Pregnancy

  • Higher doses may be needed due to pregnancy-induced pharmacokinetic changes causing reduced plasma concentrations 1
  • For β-lactams: Use prolonged infusion for maintenance after initial bolus, which reduces short-term mortality in septic shock 1
  • Balance fetal safety and transplacental drug transfer when adjusting doses 1

Fetal Surveillance

  • Implement continuous fetal heart rate monitoring for dual purposes: assessing fetal well-being and guiding maternal resuscitation 1, 4
  • Fetal surveillance provides real-time measure of maternal end-organ perfusion 1, 4
  • Expectantly manage non-reassuring fetal tracings during initial maternal stabilization, as most improve with maternal hemodynamic optimization 1, 4
  • Stabilizing the mother will typically stabilize the fetus 1, 4

Maternal Positioning and Temperature

  • Maintain lateral positioning in patients beyond 20 weeks gestation to reduce aortocaval compression and improve uteroplacental blood flow 1, 5
  • Control maternal fever to reduce fetal oxygen consumption and prevent fetal tachycardia 1, 5

Glucose Management

  • Initiate insulin therapy for persistent hyperglycemia >180 mg/dL 1
  • Target glucose range 140-180 mg/dL 1
  • Conduct bedside glucose measurements every 4 hours for at least 24 hours 1
  • Maternal hyperglycemia leads to fetal hyperglycemia, acidosis, decreased uterine blood flow, and lower fetal oxygenation 1, 4

VTE Prophylaxis

  • Administer pharmacologic VTE prophylaxis to all patients without contraindications (VTE risk up to 37% in septic patients) 1, 3
  • Low-molecular-weight heparin is preferred over unfractionated heparin due to better safety profile 1
  • Use unfractionated heparin only for specific circumstances (allergy to LMWH, imminent delivery) 1

Transfer and Escalation of Care

Criteria for Higher Level of Care

Transfer decisions should be made by multidisciplinary team when patient has: 1

  • Persistent hypotension (MAP <65 mmHg) 1
  • Need for vasopressors 1
  • Persistent hypoxia (oxygen saturation <92% on room air) 1
  • Altered mental status 1
  • Lactate ≥4 mmol/L 1

Transfer Logistics

  • Transfer to level 3 or 4 care center for pregnant patients with sepsis 1
  • Level 2 centers with ICU services capable of caring for pregnant/postpartum patients may be acceptable 1
  • Stabilize patient before transport; if delivery imminent, may be safer to postpone transfer until after childbirth 1
  • Do not delay transport due to inability to monitor fetus—maternal stabilization is priority 1

Multidisciplinary Team Engagement

  • Engage rapid response team 1
  • Consult critical care provider 1
  • Consult anesthesiology as indicated 1
  • Consult maternal-fetal medicine as indicated 1
  • Consult neonatology/pediatric provider as indicated 1

Delivery Timing

Do NOT perform immediate delivery for the sole indication of sepsis—delivery should be dictated by obstetric indications 2

Exception: If uterine source for sepsis is suspected or confirmed, perform prompt delivery or evacuation regardless of gestational age for source control 3

Common Pitfalls to Avoid

  • Do not rely on fever as a diagnostic criterion—sepsis can occur without fever in pregnancy 2, 3
  • Do not use lactate elevation during active labor as sepsis criterion 1
  • Do not delay antibiotics for culture collection if it causes substantial delay 3
  • Do not use traditional gentamicin-clindamycin regimens as first-line due to resistance patterns 1
  • Do not rush to emergent delivery for fetal distress before maternal stabilization 1, 4, 2
  • Do not use starches or gelatin for fluid resuscitation 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

SMFM Consult Series #47: Sepsis during pregnancy and the puerperium.

American journal of obstetrics and gynecology, 2019

Research

Society for Maternal-Fetal Medicine Consult Series #67: Maternal sepsis.

American journal of obstetrics and gynecology, 2023

Guideline

Risk of Fetal Sepsis from Maternal Urosepsis in Third Trimester

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sepsis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.